SANOFICONR
NSESanofi Consumer Healthcare India Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹4,616.90
15.30 (0.33%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹10.63K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
41.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹3,975+16.1%
52W High₹5,894.5-21.7%
Current Price
₹4,616.90
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹3,693.52
Upper Circuit₹5,540.28
Reference Price
₹4,616.90
Investment Checklist
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹4795.0
Head and Shoulders on 1D — target ₹3785.0
Volume divergence: Bearish (price up, volume down)
Trend: Price below most MAs — downtrend
Fundamental score 74 — strong financial health
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
41%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
4679.51
EMA50
4635.67
EMA200
4686.73
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows6
Lower Highs4
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹4670.00
₹4820.31
₹4950.17
₹5051.25
₹5255.00
Support (Below)
₹4547.83
₹4400.27
₹4080.00
₹3995.94
Volume Analysis
TrendDECREASING
Change-27.70%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹4570.73
3% Risk₹4478.39
5% Risk₹4386.05
7% Risk (Custom)
₹4293.72Technical Levels
1x ATR (Volatility)₹4471.49
2x ATR (Swing)₹4326.08
3x ATR (Trend)₹4180.67
Immediate Support₹4547.83
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹180.7 Cr | ₹172.6 Cr | ₹220.9 Cr | ₹233.9 Cr |
| Net Profit | ₹44.3 Cr | ₹50 Cr | ₹60.7 Cr | ₹62.9 Cr |
| EPS | — | ₹21.69 | ₹26.36 | ₹27.31 |
| Operating Profit | ₹64.3 Cr | ₹69.2 Cr | ₹82.4 Cr | ₹88 Cr |
ROE
66.30%
ROCE
85.51%
Debt/Equity
0.07
Current Ratio
3.00
OPM
37.62%
NPM
26.89%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 17 Apr 2025 | Dividend - Rs 55 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SANOFICONR
View All
neutral
ET Markets - Industry 4d ago
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
AONETMMQ50AONETOTALCONSUMERFOCUSGANESHCPGODREJCPHCGHCG-REHEALTHCAREJUBLCPLLIBASMEDANTASANOFICONRSKMEGGPRODTATACONSUMChemicalsConsumer Durables
neutral
Google News - India Markets 18d ago
Sanofi Consumer Healthcare India appoints PwC as statutory auditor for five-year term - scanx.trade
Sanofi Consumer Healthcare India appoints PwC as statutory auditor for five-year termscanx.trade
CONSUMERHCGHCG-REHEALTHCARESANOFISANOFICONRFinancial ServicesHealthcare
positive
LiveMint - Companies 19d ago
Schroders Capital plans to build on $1 bn India investment as scope for early investor exits grows beyond IPOs
The company is scouting for opportunities in sectors including consumer, healthcare, technology and artificial intelligence.
AKCAPITBFINVESTCONSUMERCPCAPHCGHCG-REHEALTHCARESANOFICONRFinancial ServicesHealthcare